Over 60% of the global population is located in the APAC region, which is emerging as a considerable commercial opportunity for biopharma, pharmaceutical, medical device, and healthcare companies. With ongoing reform to healthcare systems in progress, the outlook for the healthcare industry is strong, yet companies must adapt to challenges to remain competitive. APAC’s middle class is growing and pharma demand is rising across the region.
Founded in Switzerland in 2013 by Magdalena Kurpierz, KVALITO delivers smart, tailored quality & compliance services to the life science and healthcare industry. Director of KVALITO APAC, Selvi Nadarajan will lead the way in building KVALITO’s service offering throughout the APAC region, together with CEO Magdalena Kurpierz, who drives business operations in Europe, thus making KVALITO’s reach truly international. KVALITO is a strategic partner and a global life science service for regulated industries, with a focus on quality. KVALITO brings deep industry knowledge and expertise to partner with its clients to raise compliance standards and enhance patient safety globally. Kvalito’s clients range from the top 10 leading global life science and biotech companies to emerging start-ups in the healthcare sector, which innovate in business applications, devices, engineering and manufacturing. KVALITO serves clients operating in Pharmaceutical Drugs, Software as a Medical Device, Biotechnology, Life Science Technologies, Radiation-Emitting Products, Vaccines, Blood, Biologics, Animal and Veterinary Health, Hospitals, Nutraceuticals, Personalized Medical Products, Cosmetics and the Nutrition industries.
Full Article here
